Publications
Showing records 1 - 20 (of 36)
Publication: JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
ID
Author
Year
Title
Publisher
4407709 Hammann, Felix; Gotta, Verena; Conen, Katrin; Medinger, Michael; Cesana, Philipp; Rochlitz, Christoph; Taegtmeyer, Anne B.
2017
Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicity
British Journal of Clinical Pharmacology
4407708 Pagani, Olivia; Klingbiel, Dirk; Ruhstaller, Thomas; Nole, Franco; Eppenberger-Castori, Serenella; Oehlschlegel, Christian; Bernhard, Jürg; Brauchli, Peter; Hess, Dagmar; Mamot, Christoph; Munzone, Elisabetta; Pestalozzi, Bernhard C.; Rabaglio, Manuela; Aebi, Stefan; Ribi, Karin; Rochlitz, Christoph; Rothgiesser, Karin; Thürlimann, Beat; von Moos, Roger; Zaman, Khalil; Goldhirsch, Aron; Swiss Group for Clinical Cancer, Research
2017
Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99
Annals of Oncology
4407710 Laubli, H.; Tzankov, A.; Juskevicius, D.; Degen, L.; Rochlitz, C.; Stenner-Liewen, F.
2016
Lenalidomide monotherapy leads to a complete remission in refractory B-cell post-transplant lymphoproliferative disorder
Leukemia & Lymphoma
4407711 Ehrbar, V.; Urech, C.; Alder, J.; Harringer, K.; Zanetti Dallenbach, R.; Rochlitz, C.; Tschudin, S.
2016
Decision-making about fertility preservation—qualitative data on young cancer patients’ attitudes and needs
Archives of Women's Mental Health
3886346 Orleth, Annette; Mamot, Christoph; Rochlitz, Christoph; Ritschard, Reto; Alitalo, Kari; Christofori, Gerhard; Wicki, Andreas
2016
Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy
Journal of Drug Targeting
4407712 Zaman, K.; Winterhalder, R.; Mamot, C.; Hasler-Strub, U.; Rochlitz, C.; Mueller, A.; Berset, C.; Wiliders, H.; Perey, L.; Rudolf, C. B.; Hawle, H.; Rondeau, S.; Neven, P.
2015
Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: A multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08
European Journal of Cancer
4373873 Meier-Abt, F.; Bentires-Alj, M.; Rochlitz, C.
2015
Breast Cancer Prevention: Lessons to be Learned from Mechanisms of Early Pregnancy–Mediated Breast Cancer Protection
Cancer Research
4407713 Wicki, A.; Ritschard, R.; Loesch, U.; Deuster, S.; Rochlitz, C.; Mamot, C.
2015
Large-scale manufacturing of GMP-compliant anti-EGFR targeted nanocarriers: Production of doxorubicin-loaded anti-EGFR-immunoliposomes for a first-in-man clinical trial
International Journal of Pharmaceutics
4407714 Wicki, Andreas; Hermann, Frank; Prêtre, Vincent; Winterhalder, Ralph; Kueng, Marc; von Moos, Roger; Rochlitz, Christoph; Herrmann, Richard
2014
Pre-existing antihypertensive treatment predicts early increase in blood pressure during bevacizumab therapy: the prospective AVALUE cohort study
Oncol Res Treat
2819350 Huggenberger, Harriet; Ehrbar, Verena; Eichelberger, D.; Roth, Binia; Gaab, Jens; Wössmer, Brigitta; Rochlitz, Christoph; Alder, Judith
2014
Online-Unterstützung für Familien mit einem krebskranken Elternteil
Onkologische Pflege; Konferenz onkologischer Kranken- und Kinderkrankenpflege (KOK)
4407715 Templeton, Arnoud J.; Ribi, Karin; Surber, Christian; Sun, Hong; Hsu Schmitz, Shu-Fang; Beyeler, Michael; Dietrich, Daniel; Borner, Markus; Winkler, Annette; Müller, Andreas; von Rohr, Lukas; Winterhalder, Ralph C.; Rochlitz, Christoph; von Moos, Roger; Zaman, Khalil; Thürlimann, Beat J. K.; Ruhstaller, Thomas; Swiss Group for Clinical Cancer Research Coordinating Center,
2014
Prevention of palmar-plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92/08)
Breast
3135340 Wicki, Andreas; Wild, Damian; Prêtre, Vincent; Mansi, Rosalba; Orleth, Annette; Reubi, Jean-Claude; Rochlitz, Christoph; Mamot, Christoph; Mäcke, Helmut R; Christofori, Gerhard
2014
Synergism of peptide receptor-targeted Auger electron radiation therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors
EJNMMI research
2383748 Romer, A.; Seiler, D.; Marincek, N.; Brunner, P.; Koller, M. T.; Ng, Q. K. T.; Maecke, H. R.; Mueller-Brand, J.; Rochlitz, C.; Briel, M.; Schindler, C.; Walter, M. A.
2014
Somatostatin-based radiopeptide therapy with [(177)Lu-DOTA]-TOC versus [ (90)Y-DOTA]-TOC in neuroendocrine tumours
European journal of nuclear medicine and molecular imaging
4407716 Conen, Katrin L.; Fischer, Natalie; Hofbauer, Günther F. L.; Shafaeddin-Schreve, Bahar; Winterhalder, Ralph; Rochlitz, Christoph; Zippelius, Alfred
2014
Cetuximab in metastatic squamous cell cancer of the skin: a Swiss case series
Dermatology
1635005 Marincek, Nicolas; Jörg, Ann-Catherine; Brunner, Philippe; Schindler, Christian; Koller, Michael T; Rochlitz, Christoph; Müller-Brand, Jan; Maecke, Helmut R; Briel, Matthias; Walter, Martin A
2013
Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors : long-term outcome of a phase I dose escalation study
Journal of translational medicine
2832800 Bontognali, S.; Pless, M.; Brutsche, M. H.; Fischer, C.; Rochlitz, C.; Buess, M.
2013
Analysis of the EGFR mutation status in head and neck squamous cell carcinoma before treatment with Gefitinib
Onkologie
2832804 Rajski, M.; Vogel, B.; Baty, F.; Rochlitz, C.; Buess, M.
2012
Global gene expression analysis of the interaction between cancer cells and osteoblasts to predict bone metastasis in breast cancer
PLoS ONE
2832802 Mamot, Christoph; Ritschard, Reto; Wicki, Andreas; Stehle, Gregor; Dieterle, Thomas; Bubendorf, Lukas; Hilker, Christoph; Deuster, Stefanie; Herrmann, Richard; Rochlitz, Christoph
2012
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
The Lancet oncology
2832801 Mamot, Christoph; Ritschard, Reto; Wicki, Andreas; Küng, Willy; Schuller, Jan; Herrmann, Richard; Rochlitz, Christoph
2012
Immunoliposomal delivery of doxorubicin can overcome multidrug resistance mechanisms in EGFR-overexpressing tumor cells
Journal of drug targeting
1193117 Wicki, Andreas; Rochlitz, Christoph; Orleth, Annette; Ritschard, Reto; Albrecht, Imke; Herrmann, Richard; Christofori, Gerhard; Mamot, Christoph
2012
Targeting tumor-associated endothelial cells: anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growth
Clinical cancer research
Showing records 1 - 20 (of 36)
